Literature DB >> 1901508

Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat.

F B Jolicoeur1, R Rivest, A Drumheller.   

Abstract

Bilateral administration of 6-hydroxydopamine in the medial fore-brain bundle at the level of the posterolateral hypothalamus in rats resulted in hypokinesia, muscular rigidity and tremor as determined by various behavioral assessment procedures. These neurological signs were accompanied by marked decreases in the concentrations of dopamine and its main metabolites dihydroxyphenylacetic acid and homovanillic acid in both striatum and nucleus accumbens. Administration of apomorphine (1 mg/kg) or L-Dopa (60 mg/kg) reversed or totally abolished the hypokinesia, rigidity and tremor in lesioned animals. Together, the present findings demonstrate that bilateral intrahypothalamic administration of 6-OHDA results in the appearance of the three cardinal symptoms of Parkinson's disease in rats. This model should prove to be valuable for both the study of the neuropathological processes underlying the neurological signs of this disease and the screening of potential antiparkinson agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901508     DOI: 10.1016/0361-9230(91)90245-f

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

1.  A highly reproducible rotenone model of Parkinson's disease.

Authors:  Jason R Cannon; Victor Tapias; Hye Mee Na; Anthony S Honick; Robert E Drolet; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

2.  Effective deep brain stimulation suppresses low-frequency network oscillations in the basal ganglia by regularizing neural firing patterns.

Authors:  George C McConnell; Rosa Q So; Justin D Hilliard; Paola Lopomo; Warren M Grill
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

3.  Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.

Authors:  Tatyana D Sotnikova; Jean-Martin Beaulieu; Larry S Barak; William C Wetsel; Marc G Caron; Raul R Gainetdinov
Journal:  PLoS Biol       Date:  2005-08-02       Impact factor: 8.029

4.  Trunk Range of Motion Is Related to Axial Rigidity, Functional Mobility and Quality of Life in Parkinson's Disease: An Exploratory Study.

Authors:  Roberto Cano-de-la-Cuerda; Lydia Vela-Desojo; Marcos Moreno-Verdú; María Del Rosario Ferreira-Sánchez; Yolanda Macías-Macías; Juan Carlos Miangolarra-Page
Journal:  Sensors (Basel)       Date:  2020-04-27       Impact factor: 3.576

5.  Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease.

Authors:  Md Mahbubur Rahman; Rupali Rani Chakraborti; Md Abdullah Potol; Ariful Haque Abir; Ozayra Sharmin; Mahabub Alam; Md Fazlur Rahman Khan; Rownock Afrin; Humayra Jannat; Rasiqh Wadud; Zaki Farhad Habib
Journal:  Animal Model Exp Med       Date:  2019-12-30

Review 6.  Rodent models of tremor.

Authors:  Hideto Miwa
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

7.  Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease.

Authors:  Lin Li; Ke Liu; Juan Zhao; Christian Holscher; Guang-Lai Li; Yue-Ze Liu
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.